Scientific papers search

ΠΛΕΟΝΕΚΤΗΜΑΤΑ ΚΑΙ ΕΠΙΠΛΟΚΕΣ ΑΠΟ ΤΗ ΧΟΡΗΓΗΣΗ ΝΕΩΤΕΡΩΝ ΑΝΤΙΠΗΚΤΙΚΩΝ ( NOACS) ΣΚΕΥΑΣΜΑΤΩΝ ΣΕ ΓΗΡΙΑΤΡΙΚΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΔΙΟ-ΑΝΑΠΝΕΥΣΤΙΚΑ ΝΟΣΗΜΑΤΑ

Fotini Kolentsi, Theodosios Kokkios


Friday, October 1, 2021

Publication year:

2021

Authors:

Keywords index:

Pages: 231-238

DOI: 0.5281/zenodo.5938198

Abstract:

IIntroduction: The number of patients taking anticoagulants due to the increased incidence of coronary heart disease has increased in recent decades. Newer anticoagulants have recently been used in the treatment of atrial fibrillation, pulmonary embolism and deep vein thrombosis. Aim: The purpose of this review study was to highlight the benefits and complications of administering newer anticoagulants to geriatric patients with cardiorespiratory disease. Material-Methods: Data from studies, reviews and scientific articles in Pubmed and Mednet databases were used to write this review. Results: The calculation of the hemorrhagic risk as well as the ischemic events of the patients is of great importance in the decision-making for the individualization of the anticoagulation treatment. Newer oral anticoagulants offer better safety, easier use and effectiveness with the main advantage being the net clinical benefit over vitamin K blockers which increases with age in patients with Atrial Fibrillation. Conclusion: Successful anticoagulant action is determined by scientifically balancing the risk of thrombosis and its complication of bleeding, calculating the risk of bleeding and ischemic events in patients, while newer oral anticoagulants offer better safety, easier use and effectiveness.

Download PDF
European Operating Room Nurses Association
World Forum for Hospital Sterile Supply
International Federation of Perioperative Nurses